Altered Patterns of Early Metabolic Decompensation in Type 1 Diabetes During Treatment with a SGLT2 Inhibitor: An Insulin Pump Suspension Study

Background: Enthusiasm for the benefits of sodium–glucose cotransporter 2 inhibitors (SGLT2i) as an adjunctive treatment in type 1 diabetes (T1D) has been offset by the possible increased risk of diabetic ketoacidosis (DKA). Since pump-treated T1D patients are susceptible to DKA due to infusion site...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Diabetes Technol Ther
Главные авторы: Patel, Neha S., Van Name, Michelle A., Cengiz, Eda, Carria, Lori R., Weinzimer, Stuart A., Tamborlane, William V., Sherr, Jennifer L.
Формат: Artigo
Язык:Inglês
Опубликовано: Mary Ann Liebert, Inc. 2017
Предметы:
Original Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5689123/
https://ncbi.nlm.nih.gov/pubmed/29068709
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/dia.2017.0267
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы